Montreuil-sous-Bois, France

Erika Navarro-Sanchez




Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Erika Navarro-Sanchez

Introduction

Erika Navarro-Sanchez is a prominent inventor based in Montreuil-sous-Bois, France. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions against viral infections. With a total of 4 patents, her work has garnered attention in the scientific community.

Latest Patents

One of her latest patents involves the creation of chimeric polypeptides aimed at preventing or treating Flaviviridae infections. This invention not only focuses on the therapeutic use of these polypeptides but also explores their application in producing recombinant viral vectors, such as a measles living viral vector. The innovative approach taken by Navarro-Sanchez in this area highlights her commitment to advancing medical science.

Career Highlights

Throughout her career, Erika has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her research and development capabilities.

Collaborations

Erika has had the opportunity to work alongside notable colleagues, including Frederic Tangy and Marianne Lucas-Hourani. These collaborations have contributed to her success and the impact of her inventions in the scientific community.

Conclusion

Erika Navarro-Sanchez's innovative work in biotechnology, particularly her patents related to chimeric polypeptides, showcases her dedication to addressing significant health challenges. Her contributions continue to influence the field and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…